Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia

Background: Altered expression of the BCL-2 family member MCL-1 has been linked to the progression and outcome of various malignancies. Recently, MCL-1 inhibitor S63845 was reported to kill MCL-1-dependent cancer cells and has potential value in clinical application. Purpose: Herein, we reported MCL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Li, Xi-xi, Zhou, Jing-dong, Wen, Xiang-mei, Zhang, Ting-juan, Wu, De-hong, Deng, Zhao-qun, Zhang, Zhi-hui, Lian, Xin-yue, He, Pin-fang, Yao, Xin-yu, Lin, Jiang, Qian, Jun
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503339/
https://ncbi.nlm.nih.gov/pubmed/31118680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S194549
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars